| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
6e-05 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
7e-05 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
9e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
9e-05 |